Leprosy Updated

Embed Size (px)

Citation preview

  • 8/22/2019 Leprosy Updated

    1/20

    1

    Leprosy

  • 8/22/2019 Leprosy Updated

    2/20

    2

    A chronic infectious disease caused by the bacteriumMycobacteriumleprae

    It is mainly a Granulomatous disease affecting: peripheral nerves and

    mucosa of the upper-respiratory tract

    Granulomatous - refers to granulomas which are lesions of epithelioid

    macrophages

    Leprosy (Hansens Disease)

    http://www.granuloma.homestead.com/tuberculoid_leprosy_S72-6475-04.jpg
  • 8/22/2019 Leprosy Updated

    3/20

    3

    A Little History

    Gerhard Henrik Armauer Hansen wasa physician which first identified

    Mycobacterium leprae as the cause of

    leprosy in 1873

    FYI

    7/29/1841-2/12/1912

    http://en.wikipedia.org/wiki/Image:Mycobacterium_leprae.jpeghttp://en.wikipedia.org/wiki/Image:Gerhard_Hansen.jpg
  • 8/22/2019 Leprosy Updated

    4/20

    4

    A little taxonomy .

    Kingdom Bacteria

    Phylum Actinobacteria

    Order Actinomycetales

    Suborder Corynebacterineae

    Family Mycobacteriaceae

    Genus Mycobacterium

    Species M. leprae

  • 8/22/2019 Leprosy Updated

    5/20

    5

    Pathology

    Gram-positive

    Intracellular

    Aerobic rod-shaped bacillus

    With a waxy coating

    M. leprae is unable to grow in vitro

    This is thought to be due to the fact that it no longer has the genesneeded for independent growth

    Because of its inability to grow on agar, nude mice and nine-banded

    armadillos are used as animal models

  • 8/22/2019 Leprosy Updated

    6/20

    6

    Clinical Features

    Skin lesions, typically anaesthetic at the tuberculoid end ofthe spectrum

    Thickened peripheral nerves

    Acid-fast bacilli on skin smears or biopsy

    Acid-fast is a property of Mycobacteria in which they aresistant to decolorization by acids during staining

    This is a helpful diagnostic tool forM. tuberculosis andM.

    leprae

    http://en.wikipedia.org/wiki/Image:Leprosy.jpg
  • 8/22/2019 Leprosy Updated

    7/20

    7

    SymptomsTuberculoid Borderline

    Tuberculoid

    Borderline

    Lepromatous

    Borderline Lepromatous

    Skin

    Infiltrated

    lesions

    Defined plaques,

    irregular plaques,

    healing centers

    Polymorphic,

    partially raised

    edges, satellites

    Papules, nodules,

    punched-out

    centers

    Diffuse

    thickening

    Diffuse thickening

    Macular

    lesions

    Single, small Several, any

    size

    Multiple, all sizes,

    bizarre

    Innumerable,

    small

    Innumerable,

    confluent

    Peripheral

    Nerve

    lesions

    Solitary, enlarged

    nerves

    Irregular

    enlargement of

    several large

    nerves,

    asymmetrical

    patterns

    Many nerves

    involved

    symmetrical

    patterns

    Late neural

    thickening,

    asymmetrical

    anaesthesia

    and paresis

    Slow, symmetrical

    glove-and-

    stocking

    anaesthesia

    Note: Contrary to popular belief leprosy does not cause body parts to simply fall off

  • 8/22/2019 Leprosy Updated

    8/20

    8

    Tuberculoid leprosy- Patients lymphocytes respond toM. leprae in vitro

    - Skin tests with lepromin elicit a strong positive response

    - They also have a Th1- type response producing interleukin-2 and intergerons-

    - These strong cell-mediated responses clear antigens, but cause local tissuedestruction

    Lepromatous leprosy- Patients in this case do not mount a normal cell mediated response to

    M. leprae, and in fact their lymphocytes do not respond to M. leprae invitro

    - They are also unresponsive to lepromin

    - They have specific T cell failure and macrophage dysfunction, andproblems producing interleukin-2 and intergerons-

    - But they do produce Th2-type cytokins

    Immunology

  • 8/22/2019 Leprosy Updated

    9/20

    9

    Social Aspect WHO reported that at the start of 2007 there were 224,717 reported

    cases (from 109 countries and territories) In comparison with the number of new cases detected in 2006 which

    was 259,017, the number of new cases fell by more than 40,019 cases

    (a 13.4% decrease)

    In the last five years, the global number of new cases has dropped on

    average by 20% per year. Also Leprosy has been around since about 300BC

    FYI

  • 8/22/2019 Leprosy Updated

    10/20

    10

    Geographic Rage For Leprosy

  • 8/22/2019 Leprosy Updated

    11/20

    11

    Transmission

    The transmission of leprosy is thought to occur through the respiratory

    track

    Infected individuals discharge bacilli through their nose and a healthy

    individual breaths them in

    But it is important to note that the extract mechanism is not known

    The main reservoir is humans

    Risk group: children, people living in endemic areas, in poor

    conditions, with insufficient diet, or have a disease that compromises

    their immunity (ie HIV)

    In the 19th century leprosy was believed to be a hereditary ailment

    http://upload.wikimedia.org/wikipedia/commons/thumb/e/e2/Leprosy_thigh_demarcated_cutaneous_lesions.jpg/800px-Leprosy_thigh_demarcated_cutaneous_lesions.jpg
  • 8/22/2019 Leprosy Updated

    12/20

    12

    Diagnosis

    Is clinical, by finding signs of leprosy and supported with the use ofacid-fast bacilli smear or skin biopsy

    But this is contingent on experienced histopathologist

    What doctors typically look for include: anaesthesia of skin lesions,

    and peripheral nerve thickening and tenderness

    There is no serological test

    Note: The genome has been sequenced

  • 8/22/2019 Leprosy Updated

    13/20

    13

    Treatment & Management Chemotherapy

    - First line drugs are rifampicin, dapsone, and clofazimine- The WHO recommends that if a patient test positive in an acid-fast

    skin smear they should be treated for multibacillary disease

    - The patients bacterial load decides length of treatment (6-24 months)

    - Patients tend to improve quickly with minimal side-effects

    - Second line drugs are ofloxacin and minocycline- Tripledrug combinations have been used in cases where a patient has

    only a single lesion

    - Leprosy is combated with multidrug therapy to reduce the chance ofdeveloping resistance

    - Since in the 1960s resistance to dapsone developed

  • 8/22/2019 Leprosy Updated

    14/20

    14

    Multibacillary (MB or lepromatous) is a 24-month treatment of rifampicin, clofazimine, and dapsone.

    Paucibacillary (PB or tuberculoid) is a six-month treatment of rifampicin and dapsone.

    http://upload.wikimedia.org/wikipedia/commons/7/71/MDTRegimens.jpg
  • 8/22/2019 Leprosy Updated

    15/20

    15

    Treatment & Management New Nerve Damage

    - Patients with motor or sensory loss of 6 moths or less should receive a 6 monthtreatment of corticosteroids (a treatment for type 1 reactions)

    Patient Education

    - It is very important since within a few days of starting chemotherapy sincepatients will no longer be infectious and can live a normal life

    - Currently there are few leper colonies left- Also care of limbs is very important

    Preventing Disability

    - Nerve damage produces anaesthesia, dryness and muscle weakness which inturn causes misuse of affected limbs causing ulceration and infection, leading

    to deformity- Dryness can lead to skin cracking and ultimately infection

    - Treatment involves soaking and applying oil- based creams to affected areas,also physiotherapy can help prevent contractures, muscle atrophy and overstretching of muscles

    http://www.un.org/News/dh/photos/5-16leprosy.jpg
  • 8/22/2019 Leprosy Updated

    16/20

    16

    Treatment & Management Immune-Mediated Reactions

    - Type 1 reactions occur in borderline leprosy- Type 1 reactiondelayed hypersensitivity occurring at site of localizedM.

    leprae antigens

    - Skin lesions appear and are erythematous, and peripheral nerves becometender and painful

    - Loss of nerve function can be sudden (ie foot-drop)

    - Type 2 reactions occur in borderline lepromatous and lepromatous cases- Type 2 reactionerythema nodosum leprosum (ENL) results from immune

    complex deposition

    - The main symptoms are malaise, fever, and crops of small, pink nodules onface and limbs, and ENL may continue for years

    - Management procedures include : control inflammation, pain, treat neuritis,

    and halt eye damage

    Vaccines

    there currently isnt a vaccine against leprosy, but there are trials investigatingthe effectiveness of the BCG vaccine

  • 8/22/2019 Leprosy Updated

    17/20

    17

    DiscussionThalidomide (Thalomid). This drug was originally developed as a sedative and

    morning-sickness pill but was subsequently found to cause severe birth

    defects; the Food and Drug Administration then banned it. Under the newregulations there are a number of restrictions on its use:

    1. It can be used only for the treatment of erythema nodosum leprosum.

    2. Doctors who prescribe the drug and pharmacists who dispense it mustregister with

    Celgene, the company that produces it.

    3. Women must have a negative pregnancy test 24 hours before taking thedrug.

    4. Women must get weekly pregnancy tests during the first month oftreatment. Thereafter they

    must get once-a-month pregnancy tests.

    5. All thalidomide users must enroll in a registry at Boston University that

    will record anypregnancies that occur and their outcomes.

    6. All male patients must use condoms during sexual intercourse because thedrug is found in

    semen.

    http://www.kcom.edu/faculty/chamberlain/Website/tritzid/leprosy.htm

  • 8/22/2019 Leprosy Updated

    18/20

    18

    Discussion

    1) First of all lets assume that areas with highconcentrations of Leprosy could afford

    Thalidomide in addition to their basic

    treatment. What are the moral problems

    with its prescription? What are some of the

    additional problems that might arise if the

    above regulations aren't followed?

  • 8/22/2019 Leprosy Updated

    19/20

    19

    Discussion

    2)What could explain such a drop in new Leprosy cases? Considering

    the expense and length of treatment, not knowing the mode of

    transitions and the fact that most areas that are affected are still

    developing.

    Free MDT,Reducing disease burden,

    Preventing disability, Changing

    the negative image, Working

    with local governments and

    agencies

  • 8/22/2019 Leprosy Updated

    20/20

    20

    I got this off the net, I hope it helps, if anyone has any questions please email me.Can leprosy cause limbs to fall off?Leprosy does not cause flesh to rot and fingers and toes to drop off. In the past, limbs that have been damaged

    because the person cannot feel pain have sometimes had to be amputated. Now that the disease can be detectedearly and cured completely, the need to amputate is very rare.

    Who can get leprosy?Susceptibility: About 90% of the population is not susceptible to infection. Children are more susceptible than adults.Immunologic and epidemiologic studies suggest that only 10-20% of those exposed to M. lepraewill develop signs

    of indeterminate Hansen's disease; only 50% of those with indeterminate disease will develop full-blown clinical

    leprosy. Spontaneous healing also has been reported in tuberculoid leprosy.Host immunity: Where host cell-mediated immunity functions perfectly, organisms are routed and no diseasedevelops. If the individual has good immunity, organisms are contained and TT disease occurs. In subjects with

    moderate immunity, a battle occurs and results in borderline types of leprosy. In persons with poor immunity, LL

    occurs.